News

Moderna’s New Flu Shot Shows Strong Results in Older Adults
The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still ...
Oregon health Q&A: What’s the vaccine outlook for fall for COVID, flu?
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
‘This is really stressing me out.’ Answering your questions on vaccine access.
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...
Why Moderna Stock Was So Healthy This Week
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
BioSpace6d
Moderna’s Promised mRNA Flu Vaccine Bests Current Standard Shot
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
Dr. Todd Ellerin discusses new health warning on COVID-19 vaccines
Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Healio4d
Moderna reports positive phase 3 data for mRNA seasonal flu vaccine
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
NHS England10d
Flu and COVID-19 Seasonal Vaccination Programme: autumn/ winter 2025/26
PRN02047 To: integrated care boards – chief executives GP practices community pharmacies primary care networks NHS trusts – chief executives local government chief executives health and justice ...